Results 201 to 210 of about 13,431 (223)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Novel selective M3 muscarinic acetylcholine receptor ligands: Design, synthesis, and characterization

2022
Asthma and COPD are the most prevalent obstructive lung diseases worldwide and are associated with chronic airflow restriction. In the respiratory tract, smooth muscle tone is predominantly dependent on cholinergic activation of the Gq-coupled M3 muscarinic acetylcholine receptor (mAChR).
openaire   +1 more source

Muscarinic Acetylcholine Receptor M3

2020
openaire   +1 more source

M3 muscarinic acetylcholine receptor in cardiology and oncology

International Journal of Cardiology, 2014
openaire   +2 more sources

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

M3 Muscarinic Acetylcholine Receptor

2007
openaire   +1 more source

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly